Biote reports fourth quarter and full year 2023 financial results

Irving, texas--(business wire)--biote (nasdaq: btmd), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the fourth quarter and full year ended december 31, 2023. fourth quarter 2023 financial highlights (all financial result comparisons made are against the prior-year period) revenue of $45.7 million, a 2.7% increase and in line with pre-released financial guidance proc.
BTMD Ratings Summary
BTMD Quant Ranking